NORDHEALTH Aktie

 

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. Helsinki, Finland, 2 July 2025: Reference is made to the stock exchange announcement on 26 June 2025, where Nordhealth AS (the "Company") launched an offer to purchase up to 300,000 of its own shares through a reverse book building process (the "Offering"). The application period expired at 16:30 hours (CEST) on 2 July 2025. Following the end of the application...

Helsinki, Finland, 26 June 2025: Nordhealth AS (the "Company") hereby launches an offer to purchase up to 300,000 of its own shares (the "Offering"). The Offering will be carried out as a reversed book-building process where the Company, through DNB Carnegie, will receive offers for desired volume(s) for sale from the shareholders.     All shareholders in the Company are invited to sell shares in the Offering, subject to the restrictions set out herein. The Company has mandated DNB Carnegie as bookrunner for the Offering and shareholders with interest to sell shares may contact DNB...

Helsinki, Finland, 6 June 2025: Karan Wallia, a primary insider of Nordhealth AS (the "Company"), has purchased class A shares in the Company. Please refer to the attached notification of trading for further details. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20 This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12....

Helsinki, Finland, 4 June 2025: Cezary Cerekwicki, a primary insider of Nordhealth AS (the "Company"), has been granted 1,375 class A shares in the Company in accordance with the Company's performance share program. Please refer to the attached notification of trading for further details. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20 This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article...

Helsinki, Finland, 3 June 2025: Karan Wallia, a primary insider of Nordhealth AS (the "Company"), has purchased class A shares in the Company. Please refer to the attached notification of trading for further details. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20 This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12....

Helsinki, Finland, 30 May 2025: Karan Wallia, a primary insider of Nordhealth AS (the "Company"), has purchased class A shares in the Company. Please refer to the attached notification of trading for further details. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20 This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12....

The Annual General Meeting (the "AGM") of Nordhealth AS (the "Company") was held on 27 May 2025 at 10:00 hours (CET). The minutes of the AGM are attached, as well as the attendance list and voting protocol. All resolutions were approved in accordance with the proposal from the board of directors including, inter alia, a board authorization to increase the share capital with up to NOK 12,028,761.90 by issuance of new shares and to acquire treasury shares for an amount of up to NOK 12,028,761.90. These authorizations will replace the previous authorizations issued at the annual general...

Helsinki, Finland, 14 May 2025: Charles MacBain, CEO in Nordhealth AS (the "Company"), has today purchased 2,537,268 class A shares in the Company for NOK 35 per share.  Please refer to the attached notification of trading for further details. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20 This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act...

13 May 2025 – Notice is given to the shareholders of Nordhealth AS (the "Company") that the Annual General Meeting will be held on 27 May 2025 at 10:00 hours (CEST). The meeting will be conducted as a virtual meeting only. Shareholders may also participate by means of advance votes or provide a proxy with voting instructions. Pre-registration is needed for attending the meeting, see Appendix 1 of the attached notice. Deadline for the pre-registration and registration of advance votes and proxies is 23 May 2025 at 16:00 hours (CEST). For further information, please contact: Charles...

Please find attached the presentation of Nordhealth AS Q1/2025 results. The results will be presented in a live webcast and subsequent Q&A session with CEO Charles MacBain and CFO Alexander Cram on the 13th of May 2025 at 11:00 CEST. Please use the following link to attend: https://us02web.zoom.us/j/86283922219 The presentation will be recorded and made available on www.nordhealth.com For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20...

Nordhealth will report and present its Q1 2025 results on Tuesday the 13[th] of May 2025. The results will be presented in a live presentation and subsequent Q&A session with CEO Charles MacBain and CFO Alexander Cram on the 13[th] of May at 11:00 CEST. Please use the following link to attend: https://us02web.zoom.us/j/86283922219 The presentation will be recorded and made available on www.nordhealth.com. The presentation material for Q1/2025 will be available on 13[th] May 2025 at 07:30 CEST on www.newsweb.no (https://publish.ne.cision.com/l/afkpudtpe/www.newsweb.no) and on...

Please find attached Nordhealth AS Group consolidated financial statements including auditor's report for 2024. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20...

Please find attached the presentation of Nordhealth AS Q4/2024 results. The results will be presented in a live webcast and subsequent Q&A session with CEO Charles MacBain and CFO Alexander Cram on the 4th of March 2025 at 15:00 CET. Please use the following link to attend: https://us02web.zoom.us/j/87965630808 The presentation will be recorded and made available on www.nordhealth.com For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20...

Nordhealth will report and present its Q4 2024 results on Tuesday the 4[th] of March 2025. The results will be presented in a live presentation and subsequent Q&A session with CEO Charles MacBain and CFO Alexander Cram on the 4[th] of March at 15:00 CET. Please use the following link to attend: https://us02web.zoom.us/j/87965630808 The presentation will be recorded and made available on www.nordhealth.com. The presentation material for Q4/2024 will be available on 4[th] March 2025 at 07:30 CET on www.newsweb.no and on Nordhealth's IR  website https://nordhealth.com/investor/news-...

Nordhealth AS (the “Company”) is pleased to announce that it has appointed Alexander Cram as its new chief financial officer ("CFO"), effective from 3rd of February 2025. Alexander was previously CFO of Superside, a fast growing marketing services company. The decision for the departure of the existing CFO, Mari Laine, was reached through mutual agreement. Charles and the board of directors extends its gratitude to Mari for her valuable contributions to the Company over the past years....

Denver, CO – December 2024 – Provet Cloud, the cloud-based veterinary practice management software from Nordhealth, today announced a pilot program with a prominent U.S. veterinary group operating more than 200 locations. Although Provet Cloud already supports approximately 150 clinics in the United States, this marks its first partnership with a large corporate veterinary organization in North America—further solidifying the company's growing footprint in the region. Provet Cloud serves over 15,000 veterinarians in more than 2,500 veterinary clinics and hospitals worldwide, including...

Please find attached the presentation of Nordhealth AS Q3/2024 results. The results will be presented in a live webcast and subsequent Q&A session with CEO Charles MacBain and CFO Mari Laine on the 12th of November 2024 at 13:00 CET. Please use the following link to attend: https://us02web.zoom.us/j/88457477200 The presentation will be recorded and made available on www.nordhealth.com For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Mari Laine, CFO mari.laine@nordhealth.com +358 46 8765 233...

Nordhealth will report and present its Q3 2024 results on Tuesday the 12[th] of November 2024. The results will be presented in a live presentation and subsequent Q&A session with CEO Charles MacBain and CFO Mari Laine on the 12[th] of November at 13:00 CET. Please use the following link to attend: https://us02web.zoom.us/j/88457477200 The presentation will be recorded and made available on www.nordhealth.com. The presentation material for Q3/2024 will be available on 12 November 2024 at 07:30 am CET on www.newsweb.no and on Nordhealth's IR  website https://nordhealth.com/investor/news-...

Please find attached the Q2 presentation and interim financial report of Nordhealth AS first half 2024 results. The results will be presented in a live webcast and subsequent Q&A session with CEO Charles MacBain and CFO Mari Laine on the 20[th] of August 2024 at 13:00 CET. Please use the following link to attend: https://us02web.zoom.us/j/84944459012 The presentation will be recorded and made available on www.nordhealth.com. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Mari Laine, CFO mari.laine@nordhealth.com...

Nordhealth will report and present its Q2 2024 results on Tuesday the 20[th] of August 2024. The results will be presented in a live presentation and subsequent Q&A session with CEO Charles MacBain and CFO Mari Laine on the 20[th] of August at 13:00 CET. Please use the following link to attend: https://us02web.zoom.us/j/84944459012 The presentation will be recorded and made available on www.nordhealth.com. The presentation material for Q2/2024 and the 1H/2024 interim financial report will be available on 20 August 2024 at 07:30 am CET on www.newsweb.no and on Nordhealth's IR  website...